{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T15:57:43Z","timestamp":1780934263225,"version":"3.54.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100002590","name":"American Lung Association","doi-asserted-by":"publisher","award":["(LCD-1035035)"],"award-info":[{"award-number":["(LCD-1035035)"]}],"id":[{"id":"10.13039\/100002590","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["(R35GM152126)"],"award-info":[{"award-number":["(R35GM152126)"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R01CA220273"],"award-info":[{"award-number":["R01CA220273"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NIMHD Endowment award","award":["S21MD012472"],"award-info":[{"award-number":["S21MD012472"]}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RP201046"],"award-info":[{"award-number":["RP201046"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-41933-1","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T16:05:55Z","timestamp":1772726755000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["An MIEN1-based hexamer peptide (LA3IK) inhibits EGF-driven oncogenic signaling in prostate cancer by disrupting EGFR\u2013ERBB2 heterodimerization"],"prefix":"10.1038","volume":"16","author":[{"given":"Amit K.","family":"Tripathi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nafees","family":"Ahamad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antariksh","family":"Tyagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedicta","family":"Quainoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam W.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pragati","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirupama","family":"Sabnis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamboor K.","family":"Vishwanatha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,5]]},"reference":[{"key":"41933_CR1","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1038\/sj.bjc.6605376","volume":"101","author":"AM Traish","year":"2009","unstructured":"Traish, A. M. & Morgentaler, A. Epidermal growth factor receptor expression escapes androgen regulation in prostate cancer: A potential molecular switch for tumour growth. Br. J. Cancer 101, 1949\u20131956. https:\/\/doi.org\/10.1038\/sj.bjc.6605376 (2009).","journal-title":"Br. J. Cancer"},{"key":"41933_CR2","first-page":"3438","volume":"8","author":"G Di Lorenzo","year":"2002","unstructured":"Di Lorenzo, G. et al. Expression of epidermal growth factor receptor correlates with disease relapse and progression to androgen-independence in human prostate cancer. Clin. Cancer Res. 8, 3438\u20133444 (2002).","journal-title":"Clin. Cancer Res."},{"key":"41933_CR3","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1634\/theoncologist.2014-0154","volume":"20","author":"M Burotto","year":"2015","unstructured":"Burotto, M., Manasanch, E. E., Wilkerson, J. & Fojo, T. Gefitinib and erlotinib in metastatic non-small cell lung cancer: A meta-analysis of toxicity and efficacy of randomized clinical trials. Oncologist 20, 400\u2013410. https:\/\/doi.org\/10.1634\/theoncologist.2014-0154 (2015).","journal-title":"Oncologist"},{"key":"41933_CR4","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1593\/neo.14182","volume":"16","author":"A Ahsan","year":"2014","unstructured":"Ahsan, A. et al. Efficacy of an EGFR-specific peptide against EGFR-dependent cancer cell lines and tumor xenografts. Neoplasia 16, 105\u2013114. https:\/\/doi.org\/10.1593\/neo.14182 (2014).","journal-title":"Neoplasia"},{"key":"41933_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0049702","volume":"7","author":"AD Boran","year":"2012","unstructured":"Boran, A. D. et al. A potential peptide therapeutic derived from the juxtamembrane domain of the epidermal growth factor receptor. PLoS ONE 7, e49702. https:\/\/doi.org\/10.1371\/journal.pone.0049702 (2012).","journal-title":"PLoS ONE"},{"key":"41933_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-38574-y","volume":"9","author":"H Hossein-Nejad-Ariani","year":"2019","unstructured":"Hossein-Nejad-Ariani, H., Althagafi, E. & Kaur, K. Small peptide ligands for targeting EGFR in triple negative breast cancer cells. Sci. Rep. 9, 2723. https:\/\/doi.org\/10.1038\/s41598-019-38574-y (2019).","journal-title":"Sci. Rep."},{"key":"41933_CR7","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1158\/1535-7163.1615.3.12","volume":"3","author":"DJ Marciniak","year":"2004","unstructured":"Marciniak, D. J., Rishi, A. K., Sarkar, F. H. & Majumdar, A. P. Epidermal growth factor receptor-related peptide inhibits growth of PC-3 prostate cancer cells. Mol. Cancer Ther. 3, 1615\u20131621 (2004).","journal-title":"Mol. Cancer Ther."},{"key":"41933_CR8","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1002\/cbic.201500525","volume":"17","author":"S Guardiola","year":"2016","unstructured":"Guardiola, S. et al. Peptides targeting EGF block the EGF-EGFR interaction. ChemBioChem 17, 702\u2013711. https:\/\/doi.org\/10.1002\/cbic.201500525 (2016).","journal-title":"ChemBioChem"},{"key":"41933_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2024.105680","volume":"300","author":"AK Tripathi","year":"2024","unstructured":"Tripathi, A. K. et al. Short peptides based on the conserved regions of MIEN1 protein exhibit anticancer activity by targeting the MIEN1 signaling pathway. J. Biol. Chem. 300, 105680. https:\/\/doi.org\/10.1016\/j.jbc.2024.105680 (2024).","journal-title":"J. Biol. Chem."},{"key":"41933_CR10","doi-asserted-by":"publisher","first-page":"6762","DOI":"10.1158\/0008-5472.CAN-08-0107","volume":"68","author":"RJ Jin","year":"2008","unstructured":"Jin, R. J. et al. The nuclear factor-kappaB pathway controls the progression of prostate cancer to androgen-independent growth. Cancer Res. 68, 6762\u20136769. https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-0107 (2008).","journal-title":"Cancer Res."},{"key":"41933_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15010212","author":"PP Desai","year":"2022","unstructured":"Desai, P. P. et al. Combination of small extracellular vesicle-derived Annexin A2 protein and mRNA as a potential predictive biomarker for chemotherapy responsiveness in aggressive triple-negative breast cancer. Cancers (Basel) https:\/\/doi.org\/10.3390\/cancers15010212 (2022).","journal-title":"Cancers (Basel)"},{"key":"41933_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15020662","author":"JB Lampe","year":"2023","unstructured":"Lampe, J. B. et al. Cabazitaxel-loaded nanoparticles reduce the invasiveness in metastatic prostate cancer cells: Beyond the classical taxane function. Pharmaceutics https:\/\/doi.org\/10.3390\/pharmaceutics15020662 (2023).","journal-title":"Pharmaceutics"},{"key":"41933_CR13","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/s41587-019-0201-4","volume":"37","author":"D Kim","year":"2019","unstructured":"Kim, D., Paggi, J. M., Park, C., Bennett, C. & Salzberg, S. L. Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype. Nat. Biotechnol. 37, 907\u2013915. https:\/\/doi.org\/10.1038\/s41587-019-0201-4 (2019).","journal-title":"Nat. Biotechnol."},{"key":"41933_CR14","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nbt.3122","volume":"33","author":"M Pertea","year":"2015","unstructured":"Pertea, M. et al. StringTie enables improved reconstruction of a transcriptome from RNA-seq reads. Nat. Biotechnol. 33, 290\u2013295. https:\/\/doi.org\/10.1038\/nbt.3122 (2015).","journal-title":"Nat. Biotechnol."},{"key":"41933_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550. https:\/\/doi.org\/10.1186\/s13059-014-0550-8 (2014).","journal-title":"Genome Biol."},{"key":"41933_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-023-01241-z","volume":"15","author":"HL Mumme","year":"2023","unstructured":"Mumme, H. L. et al. Single-cell RNA sequencing distinctly characterizes the wide heterogeneity in pediatric mixed phenotype acute leukemia. Genome Med. 15, 83. https:\/\/doi.org\/10.1186\/s13073-023-01241-z (2023).","journal-title":"Genome Med."},{"key":"41933_CR17","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1093\/procel\/pwad004","volume":"14","author":"Y Wang","year":"2023","unstructured":"Wang, Y. et al. Longitudinal proteomic investigation of COVID-19 vaccination. Protein Cell 14, 668\u2013682. https:\/\/doi.org\/10.1093\/procel\/pwad004 (2023).","journal-title":"Protein Cell"},{"key":"41933_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-024-01590-1","volume":"22","author":"P Quan","year":"2024","unstructured":"Quan, P. et al. Single cell analysis reveals the roles and regulatory mechanisms of type-I interferons in Parkinson\u2019s disease. Cell Commun. Signal. 22, 212. https:\/\/doi.org\/10.1186\/s12964-024-01590-1 (2024).","journal-title":"Cell Commun. Signal."},{"key":"41933_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50693-3","volume":"15","author":"FA Bogaards","year":"2024","unstructured":"Bogaards, F. A. et al. Secondary integrated analysis of multi-tissue transcriptomic responses to a combined lifestyle intervention in older adults from the GOTO nonrandomized trial. Nat. Commun. 15, 7013. https:\/\/doi.org\/10.1038\/s41467-024-50693-3 (2024).","journal-title":"Nat. Commun."},{"key":"41933_CR20","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkae793","volume":"52","author":"B Polimeni","year":"2024","unstructured":"Polimeni, B., Marasca, F., Ranzani, V. & Bodega, B. IRescue: Uncertainty-aware quantification of transposable elements expression at single cell level. Nucleic Acids Res. 52, e93. https:\/\/doi.org\/10.1093\/nar\/gkae793 (2024).","journal-title":"Nucleic Acids Res."},{"key":"41933_CR21","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.actbio.2017.05.007","volume":"57","author":"AK Tripathi","year":"2017","unstructured":"Tripathi, A. K. et al. Selective phenylalanine to proline substitution for improved antimicrobial and anticancer activities of peptides designed on phenylalanine heptad repeat. Acta Biomater. 57, 170\u2013186. https:\/\/doi.org\/10.1016\/j.actbio.2017.05.007 (2017).","journal-title":"Acta Biomater."},{"key":"41933_CR22","doi-asserted-by":"publisher","first-page":"8342","DOI":"10.1021\/ja501948w","volume":"136","author":"WD Comar","year":"2014","unstructured":"Comar, W. D., Schubert, S. M., Jastrzebska, B., Palczewski, K. & Smith, A. W. Time-resolved fluorescence spectroscopy measures clustering and mobility of a G protein-coupled receptor opsin in live cell membranes. J. Am. Chem. Soc. 136, 8342\u20138349. https:\/\/doi.org\/10.1021\/ja501948w (2014).","journal-title":"J. Am. Chem. Soc."},{"key":"41933_CR23","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ymeth.2018.02.002","volume":"140","author":"MJ Kaliszewski","year":"2018","unstructured":"Kaliszewski, M. J. et al. Quantifying membrane protein oligomerization with fluorescence cross-correlation spectroscopy. Methods 140, 40\u201351. https:\/\/doi.org\/10.1016\/j.ymeth.2018.02.002 (2018).","journal-title":"Methods"},{"key":"41933_CR24","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1126\/science.adg5314","volume":"382","author":"X Shi","year":"2023","unstructured":"Shi, X. et al. Time-resolved live-cell spectroscopy reveals EphA2 multimeric assembly. Science 382, 1042\u20131050. https:\/\/doi.org\/10.1126\/science.adg5314 (2023).","journal-title":"Science"},{"key":"41933_CR25","doi-asserted-by":"publisher","DOI":"10.1289\/EHP8222","volume":"129","author":"JE Hardesty","year":"2021","unstructured":"Hardesty, J. E. et al. Effect of epidermal growth factor treatment and polychlorinated biphenyl exposure in a dietary-exposure mouse model of steatohepatitis. Environ. Health Perspect. 129, 37010. https:\/\/doi.org\/10.1289\/EHP8222 (2021).","journal-title":"Environ. Health Perspect."},{"key":"41933_CR26","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/j.celrep.2017.04.048","volume":"19","author":"YP Yang","year":"2017","unstructured":"Yang, Y. P. et al. A chimeric Egfr protein reporter mouse reveals Egfr localization and trafficking in vivo. Cell Rep. 19, 1257\u20131267. https:\/\/doi.org\/10.1016\/j.celrep.2017.04.048 (2017).","journal-title":"Cell Rep."},{"key":"41933_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0294236","volume":"18","author":"D Tang","year":"2023","unstructured":"Tang, D. et al. SRplot: A free online platform for data visualization and graphing. PLoS ONE 18, e0294236. https:\/\/doi.org\/10.1371\/journal.pone.0294236 (2023).","journal-title":"PLoS ONE"},{"key":"41933_CR28","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1093\/bioinformatics\/btt703","volume":"30","author":"A Kramer","year":"2014","unstructured":"Kramer, A., Green, J., Pollard, J. Jr. & Tugendreich, S. Causal analysis approaches in Ingenuity Pathway Analysis. Bioinformatics 30, 523\u2013530. https:\/\/doi.org\/10.1093\/bioinformatics\/btt703 (2014).","journal-title":"Bioinformatics"},{"key":"41933_CR29","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1002\/pros.20903","volume":"69","author":"AM DeHaan","year":"2009","unstructured":"DeHaan, A. M., Wolters, N. M., Keller, E. T. & Ignatoski, K. M. EGFR ligand switch in late stage prostate cancer contributes to changes in cell signaling and bone remodeling. Prostate 69, 528\u2013537. https:\/\/doi.org\/10.1002\/pros.20903 (2009).","journal-title":"Prostate"},{"key":"41933_CR30","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1080\/15384047.2015.1016689","volume":"16","author":"Q Zhen","year":"2015","unstructured":"Zhen, Q. et al. Endothelial PAS domain-containing protein 1 confers TKI-resistance by mediating EGFR and MET pathways in non-small cell lung cancer cells. Cancer Biol. Ther. 16, 549\u2013557. https:\/\/doi.org\/10.1080\/15384047.2015.1016689 (2015).","journal-title":"Cancer Biol. Ther."},{"key":"41933_CR31","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1002\/cncr.10774","volume":"95","author":"E Sivridis","year":"2002","unstructured":"Sivridis, E. et al. Association of hypoxia-inducible factors 1alpha and 2alpha with activated angiogenic pathways and prognosis in patients with endometrial carcinoma. Cancer 95, 1055\u20131063. https:\/\/doi.org\/10.1002\/cncr.10774 (2002).","journal-title":"Cancer"},{"key":"41933_CR32","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1002\/(sici)1097-0215(19980911)77:6<923::aid-ijc21>3.0.co;2-0","volume":"77","author":"J Gresham","year":"1998","unstructured":"Gresham, J. et al. Involvement of Shc in the signaling response of human prostate tumor cell lines to epidermal growth factor. Int. J. Cancer 77, 923\u2013927. https:\/\/doi.org\/10.1002\/(sici)1097-0215(19980911)77:6%3c923::aid-ijc21%3e3.0.co;2-0 (1998).","journal-title":"Int. J. Cancer"},{"key":"41933_CR33","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.cellsig.2019.05.004","volume":"61","author":"S Yao","year":"2019","unstructured":"Yao, S. et al. Angio-associated migratory cell protein interacts with epidermal growth factor receptor and enhances proliferation and drug resistance in human non-small cell lung cancer cells. Cell Signal. 61, 10\u201319. https:\/\/doi.org\/10.1016\/j.cellsig.2019.05.004 (2019).","journal-title":"Cell Signal."},{"key":"41933_CR34","first-page":"4574","volume":"9","author":"L Gao","year":"2017","unstructured":"Gao, L. et al. Integrative analysis of BSG expression in NPC through immunohistochemistry and public high-throughput gene expression data. Am. J. Transl. Res. 9, 4574\u20134592 (2017).","journal-title":"Am. J. Transl. Res."},{"key":"41933_CR35","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1016\/j.ajpath.2018.06.009","volume":"188","author":"A Tsagianni","year":"2018","unstructured":"Tsagianni, A. et al. Combined systemic disruption of MET and epidermal growth factor receptor signaling causes liver failure in normal mice. Am. J. Pathol. 188, 2223\u20132235. https:\/\/doi.org\/10.1016\/j.ajpath.2018.06.009 (2018).","journal-title":"Am. J. Pathol."},{"key":"41933_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1478331","volume":"16","author":"X Li","year":"2025","unstructured":"Li, X. et al. Unleashing the power of peptides in prostate cancer immunotherapy: Mechanism, facts and perspectives. Front. Pharmacol. 16, 1478331. https:\/\/doi.org\/10.3389\/fphar.2025.1478331 (2025).","journal-title":"Front. Pharmacol."},{"key":"41933_CR37","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a020768","volume":"6","author":"MA Lemmon","year":"2014","unstructured":"Lemmon, M. A., Schlessinger, J. & Ferguson, K. M. The EGFR family: Not so prototypical receptor tyrosine kinases. Cold Spring Harb. Perspect. Biol. 6, a020768. https:\/\/doi.org\/10.1101\/cshperspect.a020768 (2014).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"41933_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41421-023-00523-5","volume":"9","author":"X Bai","year":"2023","unstructured":"Bai, X. et al. Structure and dynamics of the EGFR\/HER2 heterodimer. Cell Discov. 9, 18. https:\/\/doi.org\/10.1038\/s41421-023-00523-5 (2023).","journal-title":"Cell Discov."},{"key":"41933_CR39","doi-asserted-by":"publisher","first-page":"3785","DOI":"10.21873\/anticanres.13527","volume":"39","author":"JY Kim","year":"2019","unstructured":"Kim, J. Y., Kim, H. S. & Yoon, S. Tyrosine kinase inhibitors Imatinib and Erlotinib increase apoptosis of antimitotic drug-resistant KBV20C cells without inhibiting P-gp. Anticancer Res. 39, 3785\u20133793. https:\/\/doi.org\/10.21873\/anticanres.13527 (2019).","journal-title":"Anticancer Res."},{"key":"41933_CR40","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1158\/0008-5472.CAN-06-3493","volume":"67","author":"G Schaefer","year":"2007","unstructured":"Schaefer, G., Shao, L., Totpal, K. & Akita, R. W. Erlotinib directly inhibits HER2 kinase activation and downstream signaling events in intact cells lacking epidermal growth factor receptor expression. Cancer Res. 67, 1228\u20131238. https:\/\/doi.org\/10.1158\/0008-5472.CAN-06-3493 (2007).","journal-title":"Cancer Res."},{"key":"41933_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0005933","volume":"4","author":"HP Kim","year":"2009","unstructured":"Kim, H. P. et al. Lapatinib, a dual EGFR and HER2 tyrosine kinase inhibitor, downregulates thymidylate synthase by inhibiting the nuclear translocation of EGFR and HER2. PLoS ONE 4, e5933. https:\/\/doi.org\/10.1371\/journal.pone.0005933 (2009).","journal-title":"PLoS ONE"},{"key":"41933_CR42","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/embor.2013.45","volume":"14","author":"F Fagotto","year":"2013","unstructured":"Fagotto, F. Looking beyond the Wnt pathway for the deep nature of beta-catenin. EMBO Rep. 14, 422\u2013433. https:\/\/doi.org\/10.1038\/embor.2013.45 (2013).","journal-title":"EMBO Rep."},{"key":"41933_CR43","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1007\/s00432-004-0581-8","volume":"130","author":"L Bonaccorsi","year":"2004","unstructured":"Bonaccorsi, L., Marchiani, S., Muratori, M., Forti, G. & Baldi, E. Gefitinib (\u2018IRESSA\u2019, ZD1839) inhibits EGF-induced invasion in prostate cancer cells by suppressing PI3 K\/AKT activation. J. Cancer Res. Clin. Oncol. 130, 604\u2013614. https:\/\/doi.org\/10.1007\/s00432-004-0581-8 (2004).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"41933_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1379389","volume":"15","author":"S Wang","year":"2024","unstructured":"Wang, S., Zhang, F. & Chen, J. Application and potential value of curcumin in prostate cancer: A meta-analysis based on animal models. Front. Pharmacol. 15, 1379389. https:\/\/doi.org\/10.3389\/fphar.2024.1379389 (2024).","journal-title":"Front. Pharmacol."},{"key":"41933_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0051655","volume":"7","author":"S Sheth","year":"2012","unstructured":"Sheth, S. et al. Resveratrol reduces prostate cancer growth and metastasis by inhibiting the Akt\/MicroRNA-21 pathway. PLoS ONE 7, e51655. https:\/\/doi.org\/10.1371\/journal.pone.0051655 (2012).","journal-title":"PLoS ONE"},{"key":"41933_CR46","doi-asserted-by":"publisher","first-page":"26879","DOI":"10.1074\/jbc.M113.492280","volume":"288","author":"A Ahsan","year":"2013","unstructured":"Ahsan, A. et al. Destabilization of the epidermal growth factor receptor (EGFR) by a peptide that inhibits EGFR binding to heat shock protein 90 and receptor dimerization. J. Biol. Chem. 288, 26879\u201326886. https:\/\/doi.org\/10.1074\/jbc.M113.492280 (2013).","journal-title":"J. Biol. Chem."},{"key":"41933_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.saa.2021.119784","volume":"257","author":"K Vladislav Victorovich","year":"2021","unstructured":"Vladislav Victorovich, K. et al. Spectra of tryptophan fluorescence are the result of co-existence of certain most abundant stabilized excited state and certain most abundant destabilized excited state. Spectrochim. Acta A Mol. Biomol. Spectrosc. 257, 119784. https:\/\/doi.org\/10.1016\/j.saa.2021.119784 (2021).","journal-title":"Spectrochim. Acta A Mol. Biomol. Spectrosc."},{"key":"41933_CR48","doi-asserted-by":"publisher","first-page":"8141","DOI":"10.1039\/c8cp07496h","volume":"21","author":"Q Shao","year":"2019","unstructured":"Shao, Q. & Zhu, W. Ligand binding effects on the activation of the EGFR extracellular domain. Phys. Chem. Chem. Phys. 21, 8141\u20138151. https:\/\/doi.org\/10.1039\/c8cp07496h (2019).","journal-title":"Phys. Chem. Chem. Phys."},{"key":"41933_CR49","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.jconrel.2022.07.018","volume":"349","author":"T Hailing","year":"2022","unstructured":"Hailing, T., Yonghong, P., Yufeng, Z. & Haitao, T. Challenges for the application of EGFR-targeting peptide GE11 in tumor diagnosis and treatment. J. Control. Release. 349, 592\u2013605. https:\/\/doi.org\/10.1016\/j.jconrel.2022.07.018 (2022).","journal-title":"J. Control. Release."},{"key":"41933_CR50","doi-asserted-by":"publisher","first-page":"11232","DOI":"10.1021\/ja504076t","volume":"136","author":"JK Sinclair","year":"2014","unstructured":"Sinclair, J. K., Denton, E. V. & Schepartz, A. Inhibiting epidermal growth factor receptor at a distance. J. Am. Chem. Soc. 136, 11232\u201311235. https:\/\/doi.org\/10.1021\/ja504076t (2014).","journal-title":"J. Am. Chem. Soc."},{"key":"41933_CR51","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1593\/neo.04379","volume":"6","author":"SS El Sheikh","year":"2004","unstructured":"El Sheikh, S. S., Domin, J., Abel, P., Stamp, G. & Lalani el, N. Phosphorylation of both EGFR and ErbB2 is a reliable predictor of prostate cancer cell proliferation in response to EGF. Neoplasia 6, 846\u2013853. https:\/\/doi.org\/10.1593\/neo.04379 (2004).","journal-title":"Neoplasia"},{"key":"41933_CR52","doi-asserted-by":"publisher","first-page":"R195","DOI":"10.1530\/ERC-19-0009","volume":"26","author":"DR Miller","year":"2019","unstructured":"Miller, D. R., Ingersoll, M. A. & Lin, M. F. ErbB-2 signaling in advanced prostate cancer progression and potential therapy. Endocr. Relat. Cancer 26, R195\u2013R209. https:\/\/doi.org\/10.1530\/ERC-19-0009 (2019).","journal-title":"Endocr. Relat. Cancer"},{"key":"41933_CR53","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s10555-016-9649-6","volume":"35","author":"JL Hsu","year":"2016","unstructured":"Hsu, J. L. & Hung, M. C. The role of HER2, EGFR, and other receptor tyrosine kinases in breast cancer. Cancer Metastasis Rev. 35, 575\u2013588. https:\/\/doi.org\/10.1007\/s10555-016-9649-6 (2016).","journal-title":"Cancer Metastasis Rev."},{"key":"41933_CR54","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1091\/mbc.10.5.1621","volume":"10","author":"Z Wang","year":"1999","unstructured":"Wang, Z., Zhang, L., Yeung, T. K. & Chen, X. Endocytosis deficiency of epidermal growth factor (EGF) receptor-ErbB2 heterodimers in response to EGF stimulation. Mol. Biol. Cell 10, 1621\u20131636. https:\/\/doi.org\/10.1091\/mbc.10.5.1621 (1999).","journal-title":"Mol. Biol. Cell"},{"key":"41933_CR55","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1158\/1940-6207.CAPR-10-0010","volume":"3","author":"K Kiguchi","year":"2010","unstructured":"Kiguchi, K. et al. Dual inhibition of both the epidermal growth factor receptor and erbB2 effectively inhibits the promotion of skin tumors during two-stage carcinogenesis. Cancer Prev. Res. (Phila.) 3, 940\u2013952. https:\/\/doi.org\/10.1158\/1940-6207.CAPR-10-0010 (2010).","journal-title":"Cancer Prev. Res. (Phila.)"},{"key":"41933_CR56","first-page":"1023","volume":"47","author":"RM Reilly","year":"2006","unstructured":"Reilly, R. M. et al. Preclinical pharmacokinetic, biodistribution, toxicology, and dosimetry studies of 111In-DTPA-human epidermal growth factor: An auger electron-emitting radiotherapeutic agent for epidermal growth factor receptor-positive breast cancer. J. Nucl. Med. 47, 1023\u20131031 (2006).","journal-title":"J. Nucl. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-41933-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-41933-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-41933-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T14:59:14Z","timestamp":1780930754000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-41933-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,5]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["41933"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-41933-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,5]]},"assertion":[{"value":"5 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this Article was revised: the Funding section contained an error in one of the grant numbers. The correct information now accompanies the original Article.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12295"}}